Filing Details
- Accession Number:
- 0001125345-18-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 17:24:14
- Reporting Period:
- 2018-03-02
- Accepted Time:
- 2018-03-06 17:24:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587774 | Blasius Eric Risser | 9704 Medical Center Drive Rockville MD 20850 | Sr Vp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-02 | 4,000 | $0.94 | 13,100 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-02 | 4,000 | $30.00 | 9,100 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock option (right to buy) | Acquisiton | 2018-03-02 | 70,000 | $0.00 | 70,000 | $28.94 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2018-03-05 | 4,000 | $0.00 | 4,000 | $0.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 70,000 | 2028-03-02 | No | 4 | A | Direct | |
| 21,497 | 2009-09-24 | 2019-03-23 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2017.
- This transaction was executed in multiple trades at prices ranging from $30.00 to $30.05.The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.
Billionaire Hedge Funds
